IB Acquisition Corp. SEC filings IBAC
IB Acquisition Corp. has 90 filings in SEC EDGAR's recent list, going back to Nov 17, 2023. Its latest annual report, Form ARS, was filed on Nov 4, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 4, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| 10-K | Annual report | Dec 26, 2024 | Sep 30, 2024 |
Showing 3 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- IBAC (Nasdaq), IBACR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1998781
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.